|Videos|June 2, 2023
Interview with BioVectra’s Marc Sauer at DCAT
Author(s)Biovectra
KEY LEARNING OBJECTIVES
- BIOVECTRA is a global CDMO with a 52 year history – and a one stop shop for our clients.
- Our growth, in recent years, has been explosive and we’ve made big moves into biologics in recent years. Our new mRNA and Biomanufacturing facility opens later this year and just adds one more capability to our menu.
- We are a trusted partner for our clients. Our tagline of “We Care” came from focus group with clients who have time and again chosen us over competitors because of the service we provide.
Related Content
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5